Hind. Unilever (HINDUNILVR)

FairStock Score: 60/100 — STEADY

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Investment Thesis

Hindustan Unilever is a high-quality, nearly debt-free FMCG franchise with exceptional ROE/ROCE and strong promoter alignment, but the stock is expensive relative to its current fundamentals. The quant picture is mixed: liquidity and the May 2026 earnings momentum signal are strong, but volume imbalance is negative and the price is far above the Graham number. Overall, this is a stalwart to hold, but not a fresh buy at current levels.

Rating: SELL (MEDIUM confidence) — 12M horizon

Strengths

• Exceptional profitability with ROE of 29.85% and ROCE of 27.85%
• Nearly debt-free balance sheet with Debt/Equity of only 0.03
• High promoter holding of 61.9% aligns management with shareholders
• Strong liquidity and low market impact, with a liquidity score of 98.5/100
• Diversified FMCG franchise with a dividend yield of 2.12%

Concerns

• P/E of 46.08 is very expensive relative to negative profit growth
• Price is far above the Graham number of ₹536.81, indicating no margin of safety
• Profit growth is negative at -3.7% and sales growth is weak at 4.4%
• Negative 5-day volume imbalance of -36.9% suggests selling pressure
• Stock is down roughly 24.5% from its 52-week high, showing weak price momentum

AI Analysis

Here is what you need to know about Hind. Unilever. This is a genuinely high-quality company. Return on equity is almost 30 percent, return on capital employed is around 28 percent, and the balance sheet is basically debt-free with a debt-to-equity of just 0.03. Promoters own about 62 percent, and you get a dividend yield around 2.1 percent. So the business is not in question. The problem is the price. The headline quote is around ₹2,077, though the data shows recent closes near ₹1,974 and an earlier May snapshot near ₹2,366. At a P/E of 46 and with profit growth actually negative at minus 3.7 percent, you are paying a premium for a company that has not been growing earnings. Sales growth is only 4.4 percent. The Graham number signal says the calculated value is about ₹537, so even at ₹2,077 the stock is far above that. That does not mean it cannot stay expensive, but it means there is no margin of safety. Now what are the quant signals saying? The May earnings momentum signal is strong, showing profit growth of 35 percent on that snapshot, but it conflicts with the current negative headline number, so I would treat it as stale. Liquidity is excellent: the market impact is low, and you can trade ₹1 crore without moving the price much. But the volume picture is cautionary. Volume is running at less than half the 20-day average, and the five-day volume imbalance is minus 37 percent. That tells me institutions are not aggressively buying; sellers are more active. Mean reversion is neutral. The z-score was only 0.4, with a half-life of about eight days, so this is not a deeply oversold bounce signal. Without CAPM alpha and Hurst data, I cannot separate market beta from stock-specific weakness, but the price itself has fallen about 24 percent from its 52-week high, which is a weak price trend. For position sizing, I would be conservative. A formal Kelly calculation with mixed signals and negative fundamental growth would justify only a tiny edge, so half-Kelly means no more than about one to one and a half percent of a diversified portfolio. My honest view: existing holders can hold because it is a stalwart franchise, but new money should wait for either a much lower price, closer to ₹1,700 or below, or clear earnings acceleration. Right now, the risk-reward is not attractive.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer